Clinical Trial Update: A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer [Phase 2]

View source ↗

Summary

Memorial Sloan Kettering Cancer Center is conducting a Phase 2 trial evaluating stereotactic body radiation therapy (SBRT) without androgen deprivation therapy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING